Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 1
2018 2
2019 2
2020 2
2021 4
2022 2
2023 10
2024 2
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Nonestrogen Therapies for Treatment of Genitourinary Syndrome of Menopause: A Systematic Review.
Casiano Evans EA, Hobson DTG, Aschkenazi SO, Alas AN, Balgobin S, Balk EM, Dieter AA, Kanter G, Orejuela FJ, Sanses TVD, Rahn DD. Casiano Evans EA, et al. Obstet Gynecol. 2023 Sep 1;142(3):555-570. doi: 10.1097/AOG.0000000000005288. Epub 2023 Aug 4. Obstet Gynecol. 2023. PMID: 37543737
Interventions and comparators were limited to seven products that are commercially available and currently in use (vaginal dehydroepiandrosterone [DHEA], ospemifene, laser or energy-based therapies, polycarbophil-based vaginal moisturizer, Tibolone, vagina …
Interventions and comparators were limited to seven products that are commercially available and currently in use (vaginal dehydroepi …
Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review.
Buzzaccarini G, Marin L, Noventa M, Vitagliano A, Riva A, Dessole F, Capobianco G, Bordin L, Andrisani A, Ambrosini G. Buzzaccarini G, et al. Climacteric. 2021 Dec;24(6):560-571. doi: 10.1080/13697137.2021.1898580. Epub 2021 Mar 24. Climacteric. 2021. PMID: 33759670
However, some contraindications limit its use, and different moisturizers or lubricants have been tested. Hyaluronic acid is a promising and widely used vaginal medical treatment with a moisturizing action and appears to provide a solution. ...W …
However, some contraindications limit its use, and different moisturizers or lubricants have been tested. Hyaluronic acid …
Effects of retinoid-loaded hyaluronic acid nanomicelles on vaginal epithelium in a murine menopause model.
Kim T, Chung HS, Lee HS, Uthaman S, Park IK, Park K. Kim T, et al. Investig Clin Urol. 2023 Mar;64(2):182-188. doi: 10.4111/icu.20220366. Investig Clin Urol. 2023. PMID: 36882178 Free PMC article.
PURPOSE: This study aimed to develop hyaluronic acid (HA)-based, retinoic acid (RA)-containing nanomicelles and to investigate the effects of these newly developed nanomicelles on regeneration of the vaginal epithelium and aquaporin 3 (AQP3) expression …
PURPOSE: This study aimed to develop hyaluronic acid (HA)-based, retinoic acid (RA)-containing nanomicelles and to inve …
Comparison of the Efficacy of Vaginal Hyaluronic Acid to Estrogen for the Treatment of Vaginal Atrophy in Postmenopausal Women: A Systematic Review.
Albalawi NS, Almohammadi MA, Albalawi AR. Albalawi NS, et al. Cureus. 2023 Aug 27;15(8):e44191. doi: 10.7759/cureus.44191. eCollection 2023 Aug. Cureus. 2023. PMID: 37767255 Free PMC article. Review.
There is a need for finding effective non-hormonal treatment for vaginal atrophy. The topical application of moisturising agents, such as hyaluronic acid (HA), represents a promising non-hormonal treatment for the relief of vaginal atrophy. ...T …
There is a need for finding effective non-hormonal treatment for vaginal atrophy. The topical application of moisturising agen …
Polycarbophil vaginal moisturizing gel versus hyaluronic acid gel in women affected by vaginal dryness in late menopausal transition: A prospective randomized trial.
Cagnacci A, Barattini DF, Casolati E, Pecoroni A, Mangrella M, Patrascu LC. Cagnacci A, et al. Eur J Obstet Gynecol Reprod Biol. 2022 Mar;270:239-245. doi: 10.1016/j.ejogrb.2022.01.021. Epub 2022 Feb 1. Eur J Obstet Gynecol Reprod Biol. 2022. PMID: 35131532 Free article. Clinical Trial.
Resulting symptoms are itching, burning, dyspareunia, and vaginal dryness (reported in up to 85%). The aim of this trial was to verify if medical device polycarbophil vaginal (PCV) moisturizer gel is not less effective than hyaluronic acid (HA) …
Resulting symptoms are itching, burning, dyspareunia, and vaginal dryness (reported in up to 85%). The aim of this trial was to verif …
Vaginal health and quality of sexual life of postmenopausal women on hyaluronic acid and Biosaccharide Gum-1 vaginal gel.
Caruso S, Bruno MT, Boemi S, Palermo G, Mazza G, Caruso G. Caruso S, et al. Taiwan J Obstet Gynecol. 2023 Sep;62(5):702-708. doi: 10.1016/j.tjog.2023.07.011. Taiwan J Obstet Gynecol. 2023. PMID: 37678998 Free article.
OBJECTIVE: To evaluate the efficacy of daily vaginal gel containing hyaluronic acid (HA) and Biosaccharide Gum-1 (BG-1) on vulvovaginal atrophy (VVA) and on sexual function and quality of life (QoL). ...Of them, 50 women on HA/BG-1 participated in the study g …
OBJECTIVE: To evaluate the efficacy of daily vaginal gel containing hyaluronic acid (HA) and Biosaccharide Gum-1 (BG-1) …
Hyaluronic acid to manage radiotoxicities in gynecological cancer patients: a scoping review.
Ribeiro LDS, Silveira RCCP, Vasques CI, de Menêses AG, Dos Reis PED, Ferreira EB. Ribeiro LDS, et al. Support Care Cancer. 2024 Jun 18;32(7):439. doi: 10.1007/s00520-024-08614-z. Support Care Cancer. 2024. PMID: 38888632
PURPOSE: This study aimed to map the use of hyaluronic acid (HA) in preventing and controlling radiotoxicity in women with gynecological cancer undergoing radiotherapy. ...There was heterogeneity in the use of HA, particularly in the method of application (moistu …
PURPOSE: This study aimed to map the use of hyaluronic acid (HA) in preventing and controlling radiotoxicity in women with gyn …
A single-arm clinical trial investigating the effectiveness of a non-hormonal, hyaluronic acid-based vaginal moisturizer in endometrial cancer survivors.
Carter J, Goldfarb S, Baser RE, Goldfrank DJ, Seidel B, Milli L, Saban S, Stabile C, Canty J, Gardner GJ, Jewell EL, Sonoda Y, Kollmeier MA, Alektiar KM. Carter J, et al. Gynecol Oncol. 2020 Aug;158(2):366-374. doi: 10.1016/j.ygyno.2020.05.025. Epub 2020 Jun 8. Gynecol Oncol. 2020. PMID: 32522420 Free PMC article. Clinical Trial.
OBJECTIVE: To assess the efficacy of non-hormonal, hyaluronic acid (HLA)-based vaginal gel in improving vulvovaginal estrogen-deprivation symptoms in women with a history of endometrial cancer. ...Vulvovaginal symptoms and pH were assessed at 4 time points (b …
OBJECTIVE: To assess the efficacy of non-hormonal, hyaluronic acid (HLA)-based vaginal gel in improving vulvovaginal es …
A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors.
Carter J, Baser RE, Goldfrank DJ, Seidel B, Milli L, Stabile C, Canty J, Saban S, Goldfarb S, Dickler MN, Gardner GJ, Jewell EL, Sonoda Y, Kollmeier MA, Alektiar KM. Carter J, et al. Support Care Cancer. 2021 Jan;29(1):311-322. doi: 10.1007/s00520-020-05472-3. Epub 2020 May 2. Support Care Cancer. 2021. PMID: 32358778 Free PMC article.
PURPOSE: To assess the feasibility and efficacy of a non-hormonal hyaluronic acid (HLA) vaginal gel in improving vulvovaginal estrogen-deprivation symptoms in postmenopausal women with a history of hormone receptor-positive (HR+) cancer. ...FSFI scores signif …
PURPOSE: To assess the feasibility and efficacy of a non-hormonal hyaluronic acid (HLA) vaginal gel in improving vulvov …
28 results